Immunofluorescence also showed that METTL3 was highly expressed in drug-resistant SCLC cell lines and that it mainly localized in the nucleus as well as a small part in the cytoplasm (Fig. 1G). The gene discussed is METTL3; the disease is small cell lung carcinoma.